Corvus Pharmaceuticals, Inc. (CRVS)
16.08
+0.06
(+0.37%)
USD |
NASDAQ |
Apr 24, 16:00
16.08
0.00 (0.00%)
After-Hours: 20:00
Corvus Pharmaceuticals EPS Diluted (Quarterly) : -0.1485 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.778 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Repligen Corp. | 0.2345 |
| Krystal Biotech, Inc. | 1.699 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.32M |
| Total Expenses (Quarterly) | 12.32M |
| Enterprise Value | 1.295B |
| Earnings Yield | -3.15% |
| Normalized Earnings Yield | -4.716 |